Literature DB >> 20020409

Comparison of fluid status in patients treated by different modalities of peritoneal dialysis using multi-frequency bioimpedance.

Andrew Davenport1, Michelle Willicombe.   

Abstract

BACKGROUND AND AIMS: Patients treated by peritoneal dialysis, especially those using automatic cyclers, are frequently found to be hypervolemic. To determine whether there are significant differences between the currently available modalities of peritoneal dialysis, we analyzed whether differences in transporter status and treatment modality had a discernible effect on extracellular fluid volumes as measured by multi-frequency bioimpedance.
METHODS: Two hundred prevalent peritoneal dialysis patients, 48% male, mean age 54.9 yr (SD+/-15.6), were studied using multi-frequency bioimpedance following a standard peritoneal equilibration test; 63 patients were treated by CAPD, 29 by APD, 96 by CCPD and 12 by OCCPD.
RESULTS: There were no differences in extracellular volumes, or extracellular volume adjusted for height, or as a ratio to total body water between the groups. As expected, extracellular volume adjusted for height depended upon bodyweight (r=0.412, p<0.001), sex (r=0.457, p<0.001) and systolic blood pressure (r=0.162, p=0.023), and extracellular volume to total body water related to the reciprocal of total daily peritoneal ultrafiltration losses (r=-0.0254, p=0.003) and urine output (-0.254, p=0.003). More importantly, on logistical regression analysis the ratio of extracellular fluid to total body fluid increased with falling albumin, F=21.5 p<0.001, increasing age, F=18.5 p<0.001, urine output F=6.46, p=0.014, total daily ultrafiltration, F=3.52 and protein intake p=0.003. Extracellular fluid adjusted for total body fluid was associated with CRP (males F=6.03, p=0.03, females F=4.438, p=0.04).
CONCLUSION: Patients were more likely to have an expanded extracellular fluid volume if they had reduced daily fluid losses, but also with biomarkers typically associated with poor nutrition and inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20020409     DOI: 10.1177/039139880903201103

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  16 in total

1.  N-terminal proBNP--marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients?

Authors:  John Booth; Jennifer Pinney; Andrew Davenport
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-27       Impact factor: 8.237

2.  Does Loss of Residual Renal Function Lead to Increased Volume Overload and Hypertension in Peritoneal Dialysis Patients?

Authors:  Stanley Fan; Andrew Davenport
Journal:  Perit Dial Int       Date:  2015-12       Impact factor: 1.756

3.  Peritoneal dialysate effluent and serum CA125 concentrations in stable peritoneal dialysis patients.

Authors:  Lynn Redahan; Andrew Davenport
Journal:  J Nephrol       Date:  2015-11-30       Impact factor: 3.902

4.  Incidence and Predictors of Zinc Deficiency in Stable Peritoneal Dialysis Patients.

Authors:  Kwanpeemai Panorchan; Andrew Davenport
Journal:  Perit Dial Int       Date:  2015 Sep-Oct       Impact factor: 1.756

5.  Effect of intra-abdominal dialysate on bioimpedance-derived fluid volume status and body composition measurements in peritoneal dialysis patients.

Authors:  Andrew Davenport
Journal:  Perit Dial Int       Date:  2013 Sep-Oct       Impact factor: 1.756

6.  Can non-invasive measurements aid clinical assessment of volume in patients with cirrhosis?

Authors:  Andrew Davenport; Banwari Argawal; Gavin Wright; Konstantinos Mantzoukis; Rumyana Dimitrova; Joseph Davar; Panayota Vasianopoulou; Andrew K Burroughs
Journal:  World J Hepatol       Date:  2013-08-27

7.  Does increased glucose exposure lead to increased body fat and reduced lean body mass in anuric peritoneal dialysis patients?

Authors:  S Fan; A Davenport
Journal:  Eur J Clin Nutr       Date:  2014-07-02       Impact factor: 4.016

8.  Changes in muscle and fat mass with haemodialysis detected by multi-frequency bioelectrical impedance analysis.

Authors:  K Panorchan; A Nongnuch; S El-Kateb; C Goodlad; A Davenport
Journal:  Eur J Clin Nutr       Date:  2015-06-03       Impact factor: 4.016

9.  Screening for muscle loss in patients established on peritoneal dialysis using bioimpedance.

Authors:  G H B Greenhall; A Davenport
Journal:  Eur J Clin Nutr       Date:  2016-10-26       Impact factor: 4.016

10.  Phosphate Removal by Peritoneal Dialysis: The Effect of Transporter Status and Peritoneal Dialysis Prescription.

Authors:  Cecile Courivaud; Andrew Davenport
Journal:  Perit Dial Int       Date:  2015-07-29       Impact factor: 1.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.